[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354009-105":59,"doc-detail-354009-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrative-bioinformatics-analysis-identifies-hccs-as-a-prognostic-and-therapeutic-biomarker-in-lung-cancer","Integrative bioinformatics analysis identifies HCCS as a prognostic and therapeutic biomarker in lung cancer","","Background: Lung cancer remains a leading cause of cancer-related mortality worldwide. Holocytochrome c synthase (HCCS), a mitochondrial enzyme linked to apoptosis and energy metabolism, has been implicated in tumorigenesis, though its lung cancer role is unclear. Aim: Determine the prognostic and therapeutic value of HCCS via integrative bioinformatics. Methods: Analyze TCGA transcriptomic, methylation, and clinical data using TNMplot, UALCAN, and TIMER2.0, then validate with meta-analysis of 18 cohorts and GEO datasets.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-bioinformatics-analysis-identifies-hccs-as-a-prognostic-and-therapeutic-biomarker-in-lung-cancer/354009/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-bioinformatics-analysis-identifies-hccs-as-a-prognostic-and-therapeutic-biomarker-in-lung-cancer/354009.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the biological role of HCCS that motivated this study?","Question",{"text":113,"@type":114},"HCCS is a mitochondrial enzyme involved in apoptosis and energy metabolism, and it contributes to cytochrome c maturation within the intrinsic apoptotic pathway.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study assess HCCS expression and its clinical relevance?",{"text":118,"@type":114},"It analyzed TCGA transcriptomic, methylation, and clinical data for HCCS expression, promoter methylation, immune infiltration, and prognostic relevance using TNMplot, UALCAN, and TIMER2.0, then performed survival analyses.",{"name":120,"@type":111,"acceptedAnswer":121},"What main findings link HCCS to lung cancer prognosis and therapy?",{"text":122,"@type":114},"HCCS was upregulated and showed promoter hypermethylation in LUAD, and low HCCS expression associated with poorer overall survival; expression also correlated with immune infiltration and mitochondrial/apoptotic pathway enrichment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354009,1791492519,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Integrative bioinformatics analysis identiﬁes HCCS as a prognostic and therapeutic biomarker in lung cancer  \nCancer Biomarkers Vol. 43(0): 1–20 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592261429264](DOI: 10.1177/18758592261429264)[ ](DOI: 10.1177/18758592261429264)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nSm Faysal Bellah 1 , Md Alim Hossen2,3  and S. M. Saker Billah4   \nAbstract  \nBackground: Lung cancer remains one of the leading causes of cancer-related mortality worldwide. Holocytochrome c synthase (HCCS), a mitochondrial enzyme involved in apoptosis and energy metabolism, has been implicated in tumorigenesis; however, its role in lung cancer is not well deﬁned.  \nAim: This study aimed to elucidate the prognostic and therapeutic potential of HCCS in lung cancer through integrative bioinformatics analyses.  \nMethods: Transcriptomic, methylation, and clinical data from TCGA were analyzed using TNMplot, UALCAN, and TIMER2.0 to evaluate HCCS expression, promoter methylation, immune inﬁltration, and prognostic relevance in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Meta-analysis of 18 independent cohorts from LUNG CANCER EXPLORER and four GEO datasets validated expression patterns, while Kaplan–Meier analysis assessed survival outcomes.  \nResults: HCCS was signiﬁcantly upregulated in LUAD and LUSC and showed promoter hypermethylation in LUAD. Meta-analysis and external validation conﬁrmed its overexpression. Patients with low HCCS expression exhibited poorer overall survival, suggesting a potential tumor-suppressive effect. HCCS expression positively correlated with immune cell inﬁltration and co-expressed genes enriched in mitochondrial and apoptotic pathways.  \nConclusion: HCCS may serve as a prognostic and therapeutic biomarker in lung cancer, linking mitochondrial regulation, epigenetic modiﬁcation, and immune interactions.  \nKeywords  \nHCCS, lung adenocarcinoma, methylation, immune inﬁltration, meta-analysis, biomarker  \nIntroduction  \nLung cancer remains a leading cause of cancer-related mortality worldwide, accounting for a signiﬁcant proportion of cancer deaths annually.1 Despite advancements in diagnostic and therapeutic strategies, the prognosis for lung cancer, particularly in advanced stages, remains poor due to late diagnosis and high metastatic potential.2 Understanding the molecular mechanisms underlying lung cancer progression is crucial for identifying novel diagnostic biomarkers and therapeutic targets. Although signiﬁcant progress has been made in cancer therapies in recent years, the overall survival rate for lung adenocarcinoma continuestoremain excessively low.3–5 Importantly, immunotherapies—particularly immune checkpoint inhibitors(ICIs)—have been approved as standard ﬁrst-line and salvage treatment strategies for patients with advanced or recurrent lung cancer.6–9 Nevertheless, most patients with lung cancer exhibit limited responsiveness to  \nICI therapy, underscoring the urgent need for reliable biomarkers that can enhance diagnosis, guide prognosis, and inform treatment strategies—especially those capable ofpredicting or modulating immunotherapy outcomes.10–12  \n1 Department of Pharmacy, Pabna University of Science and Technology, Pabna, Bangladesh  \n2Department of Physical Sciences, Independent University, Bangladesh, Dhaka, Bangladesh  \n3Bioinformatics Laboratory, Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh  \n4Department of Chemistry, National University, Gazipur, Bangladesh  \nCorresponding author:  \nSm Faysal Bellah, Department of Pharmacy, Pabna University of Science and Technology, Pabna-6600, Bangladesh.  \nEmail: [faysal_phku@yahoo.com](faysal_phku@yahoo.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution  \nNonComm","cbCaie8yuNcKAkzg","https://ap.wps.com/l/cbCaie8yuNcKAkzg","pdf",6967918,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is the biological role of HCCS that motivated this study?\",\"answer\":\"HCCS is a mitochondrial enzyme involved in apoptosis and energy metabolism, and it contributes to cytochrome c maturation within the intrinsic apoptotic pathway.\"},{\"question\":\"How did the study assess HCCS expression and its clinical relevance?\",\"answer\":\"It analyzed TCGA transcriptomic, methylation, and clinical data for HCCS expression, promoter methylation, immune infiltration, and prognostic relevance using TNMplot, UALCAN, and TIMER2.0, then performed survival analyses.\"},{\"question\":\"What main findings link HCCS to lung cancer prognosis and therapy?\",\"answer\":\"HCCS was upregulated and showed promoter hypermethylation in LUAD, and low HCCS expression associated with poorer overall survival; expression also correlated with immune infiltration and mitochondrial/apoptotic pathway enrichment.\"}]","Integrative bioinformatics analysis identifies HCCS as a prognostic and therapeutic biomarker in lung cancer | PDF",1790108452,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcce4244113e3d039287293e1a4d5216.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00b5b74be583d7c556ecf95ebebcf58c.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/085825c0c368c5fc6cd418066f0457dd.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eae82f82693b90bc91bc012acc5fd52e.webp",980,1306]